Predicting Long-Term Engraftment of Engineered Immune Cells Through Tissue-Niche Adaptation

Speciality: Gene & Cell Therapy


Speaker:

Mr. Ashwin S Krishnan | HCP

Description:

Welcome to today’s episode, where we explore how predicting the long-term engraftment of engineered immune cells can transform modern medicine. Engraftment refers to the ability of these engineered cells to survive and function in a patient’s body over time. Scientists are discovering that tissue-niche adaptation—the process by which immune cells adjust to their new tissue environments—plays a critical role in this success. By understanding the signals and conditions that encourage adaptation, researchers can design more effective cell therapies for cancer, autoimmune diseases, and more. This approach not only improves treatment outcomes but also helps personalize therapies for individual patients. Stay with us to learn how this cutting-edge research is paving the way for the future of immune cell therapy.

See More Webinars @ Hidoc Webinars




Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Three out of ten breast cancers detected between screenings, study finds

2.

Second Malignancy Risk With CAR T-Cell Therapy on Par With Other Treatments

3.

Where Did This Very Painful Gluteal Mass Come From?

4.

As compared to proton therapy, proton therapy is very effective in treating esophageal cancer.

5.

Rucaparib Delays Next Lines of Therapy in Ovarian Cancer


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot